Showing 672 news articles about New & experimental HIV treatments

Filters Content type: Editors' picks Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

Pharmaceutical industry

Over the Next Decade, the Dominance of Bristol-Myers Squibb Company 's Atripla in the HIV Drug Market Will Be Challenged by Gilead's Quad and Janssen's Complera

Editor's pick
Business Wire
28 October 2011
Pharmaceutical industry

Gilead posts higher profit, seeks Quad approval

Editor's pick
Reuters
27 October 2011
New & experimental HIV treatments

EACS: Does Maraviroc Intensification Promote Better CD4 Cell Recovery?

Editor's pick
HIVandhepatitis.com
27 October 2011
New & experimental HIV treatments

BMS to develop Reyataz fixed-dose pill with Gilead booster drug

Editor's pick
MarketWatch
26 October 2011
Pharmaceutical industry

Gilead At Crucial Stage For Next-Era HIV Meds

Editor's pick
Investor's Business Daily
19 October 2011
New & experimental HIV treatments

Boehringer signs away HIV rights to focus on hep C - InPharm

Editor's pick
InPharm
7 October 2011
Pharmaceutical industry

Gilead Sciences inks licensing deal for HIV drug -

Editor's pick
Bloomberg BusinessWeek
6 October 2011
New & experimental HIV treatments

Behind the headlines: HIV vaccine passes phase I trial

Editor's pick
NHS Choices
30 September 2011
The search for an HIV prevention vaccine

HIV vaccine is a small breakthrough, but not a cure

Editor's pick
The Guardian
29 September 2011
New & experimental HIV treatments

Biotron begins landmark phase 1b/2a human trial for HIV drug

Editor's pick
Business Spectator
29 September 2011
New & experimental HIV treatments

Off-Label Use of HIV Medications Is Catalyst for More Controversy

Editor's pick
New York Times
24 September 2011
New & experimental HIV treatments

Edurant® (rilpivirine) receives positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for use in treatment-naïve adults with HIV-1

Editor's pick
PR Newswire
23 September 2011
New & experimental HIV treatments

European CHMP Adopts Positive Opinion for Eviplera(R), a Once-Daily Single Tablet Regimen for the Treatment of HIV Infection

Editor's pick
Market Watch (press release)
23 September 2011
New & experimental HIV treatments

Targeting HIV's sugar coating

Editor's pick
Eurekalert Medicine & Health
23 September 2011
New & experimental HIV treatments

ICAAC: HIV-2 May Yield to Integrase Inhibitor

Editor's pick
MedPage Today HIV/AIDS
22 September 2011
New & experimental HIV treatments

Ibalizumab Study Casts a Ray of Hope for HIV-Infected People With Extensive Drug Resistance

Editor's pick
The Body
21 September 2011
The search for a cure

Scientists find way to "disarm" AIDS virus

Editor's pick
Reuters
20 September 2011
New & experimental HIV treatments

Gilead: Second trial of 4-drug AIDS pill meets goal

Editor's pick
Reuters
19 September 2011
The search for a cure

"Functional Cure" For HIV/AIDS Glimpsed In Small Trial

Editor's pick
HIV / AIDS News From Medical News Today
19 September 2011
New & experimental HIV treatments

Sangamo’s Blood-Cell Gene Therapy Fights HIV Without Drugs

Editor's pick
Bloomberg Business Week
19 September 2011
New & experimental HIV treatments

Sangamo gene therapy shows promise in reducing HIV

Editor's pick
Reuters
18 September 2011
The search for a cure

Sangamo’s Blood-Cell Gene Therapy Fights HIV Without Drugs

Editor's pick
Bloomberg Business Week
18 September 2011
The search for an HIV prevention vaccine

Bionor AIDS Injection Helps Patients Stay Off Pills in Study

Editor's pick
Bloomberg
15 September 2011
The search for an HIV prevention vaccine

Bionor Pharma reports phase IIb HIV therapeutic vaccine results

Editor's pick
Market Watch (press release)
14 September 2011